| Business Summary | | GlaxoSmithKline
plc
is
engaged
in
the
creation
and
discovery,
development,
manufacture
and
marketing
of
pharmaceutical
products,
vaccines,
over-the-counter
(OTC)
medicines
and
health-related
consumer
products.
GlaxoSmithKline
operates
principally
in
two
industry
segments:
Pharmaceuticals
(prescription
pharmaceuticals
and
vaccines)
and
Consumer
Healthcare
(OTC
medicines,
oral
care
and
nutritional
healthcare). | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | GlaxoSmithKline
plc
is
engaged
in
the
creation
and
discovery,
development,
manufacture
and
marketing
of
pharmaceutical
products,
vaccines,
over-the-counter
medicines
and
health-related
consumer
products.
For
the
six
months
ended
6/30/01,
sales
rose
15%
to
L9.88
billion.
Net
loss
applicable
to
Common
rose
4%
to
L1.71
billion.
Results
reflect
increased
pharmaceutical
and
consumer
healthcare
sales
partially
offset
by
increased
S/G/A
and
R&D
expenditures. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Sir Richard Sykes, 58 | Chairman | Jean-Pierre Garnier, Ph.D., 53 | CEO,
Director | John Coombe, 55 | CFO,
Director | Howard Pien, 43 | Pres,
Pharmaceuticals, International | David Stout, 46 | Pres,
US Pharmaceuticals |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|